Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases. - Concepedia

Concepedia

Publication | Closed Access

Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.

11

Citations

0

References

2009

Year

S. Tauchert, Alessandra Di Liberto, Tim Cordes, Marc Thill, Darius Salehin, Matthias G. Friedrich

Abstract

We conclude that the measurement of TRAP is useful in monitoring treatment with bisphosphonate clodronate in patients with bone metastatic breast cancer.